What is Anuh Pharma Ltd (ANUHPHR) share price return in the past 10 years?

Anuh Pharma Ltd share price has appreciated 4.2% annually (CAGR) over the past ten years.

What is the share price of Anuh Pharma Ltd (ANUHPHR)?

Company share prices are keep on changing according to the market conditions. The current trading price of Anuh Pharma Ltd (ANUHPHR) on 10-Jun-2026 12:07:00 at 12:07 is 76.71.

What is the P/E ratio of Anuh Pharma?

The latest standalone P/E ratio of Anuh Pharma as of 10-Jun-2026 is 18.95.

What is the P/B ratio of Anuh Pharma Ltd (ANUHPHR)?

The latest standalone P/B ratio of Anuh Pharma Ltd (ANUHPHR) as of 10-Jun-2026 is 2.21.

What is the 52-week high and low of Anuh Pharma Ltd (ANUHPHR)?

The 52-week high of Anuh Pharma Ltd (ANUHPHR) is Rs. 115.00 and the 52-week low is Rs. 66.72.

Anuh Pharma Ltd (ANUHPHR) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: Anuh Pharma Ltd (ANUHPHR)
Brand: Anuh Pharma

Anuh Pharma Ltd (ANUHPHR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506260 NSE: ANUHPHR Pharmaceuticals & Drugs | Small Cap | Anuh Pharma Share Price

Anuh Pharma Ltd (ANUHPHR)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 506260 NSE: ANUHPHR Pharmaceuticals & Drugs | Small Cap | Anuh Pharma Share Price

Key Metrics

Valuation Multiples

Market Cap

₹778 Cr.

Current Price

₹76.7

52-Week Low / High

₹67 / 115

TTM EPS

₹4.1

TTM Sales

₹772 Cr.

Book Value per Share

₹35.1

P/E Ratio

18.95

In line with its 5-year historical median

Industry PE

Price to Book (P/B)

2.21

Lower than its 5-year historical median

Price to Sales (P/S)

1.01

Lower than its 5-year historical median

EV/EBITDA

11.64

In line with its 5-year historical median

Dividend Yield

1.01%

Profitability Efficiency

Return on Equity (ROE)

15.34%

Outperforms industry median

Return on Capital Employed (ROCE)

19.77%

Outperforms industry median

Return on Assets (ROA)

9.97%

Operating Profit Margin

9.7%

Net Profit Margin

7.16%

Gross Profit Margin

10.5%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

2.24%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-18.77%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-21.16%

Asset Quality

Promoter Holding

71.80%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹302 Cr.

Equity

₹50.1 Cr.

Face Value

₹5

All Time Low / High

₹0.02 / 132.50

Anuh Pharma stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is Anuh Pharma Ltd a good quality company?

Anuh Pharma Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Anuh Pharma Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Anuh Pharma Ltd vs industry peers?

Anuh Pharma Ltd revenue CAGR is 16.60%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.

Q.1 Promoter shareholding and pledge status of Anuh Pharma Ltd?

Promoters hold 71.80% of the Anuh Pharma Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Anuh Pharma Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 4.8% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	34.9%	21.6%	16.3%	20.6%	10.9%	19.8%	19.3%	21.1%	29.7%	19.8%	-
Value Creation Index ⓘ	1.5	0.5	0.2	0.5	-0.2	0.4	0.4	0.5	1.1	0.4	-
Growth Parameters ⓘ
Sales ⓘ	326	206	238	321	307	432	487	527	647	662	772
Sales YoY Gr.	-	-36.8%	15.5%	34.7%	-4.3%	40.7%	12.7%	8.4%	22.7%	2.2%	-
Adj EPS ⓘ	2.7	1.9	1.5	2.5	1.8	2.3	3.1	3.7	5.8	4.7	4.1
YoY Gr.	-	-29.2%	-20.6%	63.6%	-27%	26.6%	31.8%	19.9%	57.3%	-18.5%	-
BVPS (₹) ⓘ	11.9	14	14.9	16.4	16.2	19	21.3	24.1	29.1	32.5	35.1
Adj Net Profit ⓘ	27.5	19.4	15.4	25.3	18.5	23.4	30.7	36.9	58	47.3	41
Cash Flow from Ops. ⓘ	16.5	26.1	1.8	7.1	48.9	-18.7	28.9	53.9	12.9	37.1	-
Debt/CF from Ops. ⓘ	0.1	0	1.3	0.6	0.9	-0.7	0.1	0	0.2	0.3	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	8.2%	16.6%	10.8%	2.2%
Adj EPS ⓘ	6.2%	20.7%	15.4%	-18.5%
BVPSⓘ	11.8%	15%	15.1%	11.9%
Share Price	4.2%	3.1%	15.7%	-30.2%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	25	14.9	10.6	16.1	11.3	13.3	15.2	16.2	21.8	15.3	12.1
Op. Profit Mgn % ⓘ	12.3	11	8.6	10.8	10	10.5	10.1	10.2	11.8	9.7	7.6
Net Profit Mgn % ⓘ	8.4	9.4	6.5	7.9	6	5.4	6.3	7	9	7.1	5.3
Debt to Equity ⓘ	0	0	0	0	0.3	0.1	0	0	0	0	0
Working Cap Days ⓘ	116	176	153	139	169	153	162	166	153	167	96
Cash Conv. Cycle ⓘ	33	58	62	54	47	32	50	48	50	60	52

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	326	206	238	321	307	432	487	527	647	662
Operating Expenses ⓘ +	289	183	220	291	284	387	439	476	571	600
Manufacturing Costs	18	16	16	20	21	25	27	35	41	46
Material Costs	247	149	180	241	229	328	375	399	484	496
Employee Cost	7	7	9	10	13	14	15	17	19	23
Other Costs ⓘ	17	11	15	19	21	20	21	25	27	34
Operating Profit ⓘ	38	23	18	30	23	45	47	52	76	62
Operating Profit Margin (%)	11.5%	11.0%	7.7%	9.3%	7.6%	10.4%	9.8%	9.8%	11.7%	9.3%
Other Income ⓘ +	4	8	7	5	4	11	5	6	12	9
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	1	1	0	1	1	2	2	1	1	1
Depreciation ⓘ	2	2	2	2	7	15	12	10	9	9
Profit Before Tax ⓘ	38	28	23	32	19	39	39	47	78	61
Tax ⓘ	12	8	7	9	5	10	9	11	18	14
Profit After Tax	26	20	17	23	14	28	31	36	60	47
PAT Margin (%)	7.9%	9.7%	6.9%	7.3%	4.7%	6.6%	6.3%	6.9%	9.3%	7.2%
Adjusted EPS (₹)	2.6	2.0	1.7	2.3	1.4	2.8	3.1	3.6	6.0	4.7
Dividend Payout Ratio (%)	24.30%	31.20%	41.70%	29.50%	48.20%	26.40%	28.70%	27.70%	20.90%	15.90%

Valuation of Anuh Pharma - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	119	141	150	165	162	191	214	241	291	326
Share Capital ⓘ	13	13	13	13	13	25	25	25	25	25
Reserves ⓘ	107	128	137	152	150	166	189	216	266	301
Debt +	2	0	2	4	45	14	3	0	2	10
Long Term Debt	0	0	0	0	0	0	0	0	0	0
Short Term Debt	2	0	2	4	45	14	3	0	2	10
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	52	42	52	59	105	120	122	153	141	157
Others Liabilities ⓘ	18	5	4	11	15	8	9	10	12	11
Total Liabilities ⓘ	191	187	208	239	326	333	347	404	445	505
Fixed Assets
Net Fixed Assets ⓘ +	18	17	17	21	84	71	61	53	49	58
Gross Block	33	19	20	27	96	98	100	100	104	120
Accumulated Depreciation	15	2	4	5	12	27	38	47	55	62
CWIP ⓘ	0	0	6	34	0	0	0	0	0	0
Investments ⓘ	43	70	66	39	80	31	43	91	97	106
Inventories	24	30	32	43	61	81	80	73	75	74
Trade Receivables	75	57	71	75	81	107	136	171	190	216
Cash Equivalents	13	6	8	11	3	20	16	7	8	20
Others Assets ⓘ	18	7	8	17	18	21	11	10	25	30
Total Assets ⓘ	191	187	208	239	326	333	347	404	445	505

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	16	26	2	7	49	-19	29	54	13	37
PBT ⓘ	38	28	23	32	19	39	39	47	78	61
Adjustment ⓘ	-1	-5	-2	-2	8	7	8	4	-3	0
Changes in Working Capital ⓘ	-8	11	-13	-13	27	-55	-9	16	-44	-13
Tax Paid ⓘ	-13	-8	-7	-10	-5	-10	-9	-13	-19	-11
Cash Flow From Investing Activity ⓘ +	-5	-20	2	3	-77	52	-8	-43	1	-20
Capex	-11	-1	-7	-29	-36	-6	-1	-1	-5	-20
Net Investments	3	-23	6	29	-43	56	-9	-44	5	-1
Others ⓘ	3	4	3	3	3	2	2	2	1	1
Cash Flow From Financing Activity ⓘ +	-9	-4	-5	-7	22	-33	-19	-12	-9	-5
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0	-0	-0	-0	-1	-2	-1	-0	-0	-0
Dividend Paid ⓘ	-11	-2	-8	-8	-17	0	-8	-9	-10	-13
Others ⓘ	2	-2	2	2	39	-32	-11	-3	2	8
Net Cash Flow ⓘ	2	2	-1	3	-5	0	2	-2	5	12

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	23.44	15.43	11.38	14.87	8.75	16.12	15.11	15.9	22.56	15.34
ROCE (%)	34.91	21.61	16.31	20.56	10.87	19.75	19.33	21.05	29.66	19.77
Asset Turnover Ratio	1.9	1.15	1.23	1.44	1.12	1.34	1.44	1.41	1.53	1.4
PAT to CFO Conversion(x)	0.62	1.3	0.12	0.3	3.5	-0.68	0.94	1.5	0.22	0.79
Working Capital Days
Receivable Days	76.30	110.50	95.70	82.40	89.30	77.90	90.20	105.70	101.40	111.10
Inventory Days	21.40	45	46.30	42.30	59.90	59.20	60	52.50	41.60	41
Payable Days	74.10	115.40	95.70	83.80	130.60	125.20	117.40	125.50	110.70	109.40

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Anuh Pharma Ltd FAQs

The current trading price of Anuh Pharma on 10-Jun-2026 12:07 is ₹76.71.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 09-Jun-2026 the market cap of Anuh Pharma stood at ₹777.6 Cr

The latest P/E ratio of Anuh Pharma as of 09-Jun-2026 is 18.95.

The latest P/B ratio of Anuh Pharma as of 09-Jun-2026 is 2.21.

The 52-week high of Anuh Pharma is ₹115.0 and the 52-week low is ₹66.72.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Anuh Pharma is ₹772 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Anuh Pharma Ltd is a good quality company.

The key valuation ratios of Anuh Pharma Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Semi Strong which suggest that the price of Anuh Pharma Ltd is likely to Rise-somewhat in the short term. However, please check the rating on Quality and Valuation before investing.

About Anuh Pharma Ltd

Anuh Pharma incorporated in 1960, is one of the leading manufacturers of Active Pharmaceutical Ingredients (APIs). The company is part of the SK Group, which has evolved as a leading importer, exporter, distributor and manufacturer of bulk drugs, chemicals and pharmaceutical formulations.

The company has grown several immensely and earned recognition, besides gaining the trust of a strong customer base. Today, it is one of the largest producers of macrolides in the country.

Anuh Pharma has a product presence in Africa, Asia, Europe, Central/South America and the Middle East. The company's registered office is at E-17/3 and 17/4 MIDC, Tarapur, Boisar, Thane District 401506

Products

Macrolides
Higher Macrolides
Quinolones
Chloramphenicol
Anti TB Drug
Corticosteroids

Recognitions/Certifications

Anuh Pharma has received â€˜Star Export Houseâ€™ certification from the Ministry of Commerce and Industry.
The company received WHO-GMP certificate for carrying good manufacturing practices.
Anuh Pharma has received ISO 9001:2000 certification

Anuh Pharma Ltd (ANUHPHR)

Anuh Pharma Ltd (ANUHPHR)

Anuh Pharma stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Anuh Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Anuh Pharma Ltd FAQs

About Anuh Pharma Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Anuh Pharma Ltd (ANUHPHR)

Anuh Pharma Ltd (ANUHPHR)

Anuh Pharma stock performance

Check Before You Invest

Quality

Valuation

Price Trend

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Anuh Pharma - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Anuh Pharma Ltd FAQs

What is the share price of Anuh Pharma?

What is the market cap of Anuh Pharma?

What is the P/E ratio of Anuh Pharma?

What is the P/B ratio of Anuh Pharma?

What is the 52-week high and low of Anuh Pharma?

What is the TTM revenue of Anuh Pharma?

Is Anuh Pharma Ltd a good quality company?

Is Anuh Pharma Ltd undervalued or overvalued?

Is Anuh Pharma Ltd a good buy now?

About Anuh Pharma Ltd

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.